VANCOUVER, British Columbia, April 12, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced ...
LAFAYETTE, Colo.-- The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc., and 14 leading international research centers pioneering the use of whole-genome RNAi screening ...
Avidity expands its leading RNA delivery technology into precision cardiology with two new wholly-owned development candidates targeting rare genetic cardiomyopathies: AOC 1086 to treat PLN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback